# A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children

> **NCT02211729** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 22090 (actual)

## Conditions studied

- Malaria
- Respiratory Infections

## Interventions

- **DRUG:** Sulphadoxine-Pyrimethamine+ Amodiaquine+ Azithromycin
- **DRUG:** Sulphadoxine-pyrimethamine + amodiaquine + placebo azithromycin

## Key facts

- **NCT ID:** NCT02211729
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 22090 (ACTUAL)
- **Last updated:** 2018-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02211729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02211729, "A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02211729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*